Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity

J Nucl Med. 1992 Mar;33(3):325-9.

Abstract

To evaluate the relationship between PET using 18F-fluorodeoxyglucose (FDG) and pathological findings and to compare indices obtained by FDG-PET, FDG-PET was performed in 23 patients with untreated malignant lymphoma. Three indices obtained by FDG-PET, tumor-to-normal contrast ratio (TCR), distribution absorption ratio (DAR), k1k2/(k2 + k3), correlated with proliferative activity which was pathologically estimated both by mitotic count and by proportion of cells in all phases of the cell cycle. The relationship did not significantly change according to which of the three indices was chosen. FDG-PET, which shows the proliferative activity of tumors, is considered to be a useful method for managing tumors.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Division
  • Deoxyglucose / analogs & derivatives*
  • Female
  • Fluorodeoxyglucose F18
  • Hodgkin Disease / diagnostic imaging*
  • Hodgkin Disease / pathology
  • Humans
  • Ki-67 Antigen
  • Male
  • Middle Aged
  • Mitotic Index
  • Nuclear Proteins*
  • Tomography, Emission-Computed*

Substances

  • Ki-67 Antigen
  • Nuclear Proteins
  • Fluorodeoxyglucose F18
  • Deoxyglucose